Sfoglia per Autore  ZANGRILLI, ARIANNA

opzioni
Mostrati risultati da 1 a 20 di 30
Data di pubblicazione Titolo Autore(i) Tipo File
1-gen-2005 Clinical severity instruments Zangrilli, A; Talamonti, M; Saraceno, R; Chimenti, S Contributo in libro
1-gen-2007 Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics Papoutsaki, M; Chimenti, Ms; Costanzo, A; Talamonti, M; Zangrilli, A; Giunta, A; Bianchi, L; Chimenti, S Articolo su rivista
1-gen-2007 Erysipeloid cutaneous metastasis from bladder carcinoma Zangrilli, A; Saraceno, R; Sarmati, L; Orlandi, A; Bianchi, L; Chimenti, S Articolo su rivista
1-gen-2008 Adalimumab for moderate to severe psoriasis: an open-label, retrospective 3-year study Papoutsaki, M; Chimenti, Ms; Talamonti, M; Zangrilli, A; Teoli, M; Kroegler, B; Perricone, R; Chimenti, S Intervento a convegno
1-gen-2008 Long-term efficacy of adalimumab in generalized pustular psoriasis Zangrilli, A; Papoutsaki, M; Talamonti, M; Chimenti, S Articolo su rivista
1-gen-2009 Radiologically significant joint improvement in a patient affected by psoriatic arthritis treated with adalimumab Chimenti, Ms; Papoutsaki, M; Teoli, M; Zangrilli, A; Perricone, R; Chimenti, S Articolo su rivista
1-gen-2013 Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study Esposito, M; Giunta, A; Mazzotta, A; Zangrilli, A; Babino, G; Bavetta, M; Perricone, R; Chimenti, S; Chimenti, Ms Articolo su rivista
1-gen-2013 Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis Saraceno, R; Bavetta, M; Zangrilli, A; Chiricozzi, A; Potenza, C; Chimenti, S; Chimenti, Ms Articolo su rivista
1-gen-2013 TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis Saraceno, R; Pietroleonardo, L; Mazzotta, A; Zangrilli, A; Bianchi, L; Chimenti, S Articolo su rivista
1-nov-2014 Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations Marinari, B; Botti, E; Bavetta, M; Spallone, G; Zangrilli, A; Talamonti, M; Richetta, A; Chimenti, S; Costanzo, A Articolo su rivista
1-gen-2015 Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk Chiricozzi, A; Bianchi, L; Zangrilli, A; Bavetta, M; Giunta, A; Chimenti, S; Saraceno, R Articolo su rivista
1-gen-2017 HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study. Talamonti, M; Galluzzo, M; Zangrilli, A; Papoutsaki, M; Egan, C; Bavetta, M; Tambone, S; Fargnoli, M; Bianchi, L Articolo su rivista
1-gen-2017 Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. Chiricozzi, A; Zangrilli, A; Bavetta, M; Bianchi, L; Chimenti, S; Saraceno, R Articolo su rivista
1-gen-2018 Paradoxical case effects of psoriasis following adalimumab therapy: A case series Zangrilli, A; Bavetta, M; Mazzilli, S; Garofalo, V; Bianchi, L Articolo su rivista
1-gen-2018 Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey Potenza, M; Peris, K; Berardesca, E; Bianchi, L; Richetta, A; Bernardini, N; De Simone, C; Teoli, M; Zangrilli, A; D’Epiro, S; Orsini, D; Narcisi, A; Chimenti, S; Costanzo, A Articolo su rivista
1-gen-2018 Long-term treatment of psoriatic patients with adalimumab reduces disease severity and maintains a favorable lipid pattern and a low Atherogenic Index. Zangrilli, A; Bavetta, M; Scaramella, M; Bianchi, L Articolo su rivista
1-gen-2018 Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey Potenza, Mc; Peris, K; Berardesca, E; Bianchi, L; Richetta, A; Bernardini, N; De Simone, C; Teoli, M; Zangrilli, A; D'Epiro, S; Orsini, D; Narcisi, A; Chimenti, S; Costanzo, A Articolo su rivista
1-gen-2019 One drug and two diseases: A case of multidrug-resistant hidradenitis suppurativa and psoriasis treated with apremilast Lanna, C; Mazzilli, S; Zangrilli, A; Bianchi, L; Campione, E Articolo su rivista
1-gen-2019 Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice Esposito, M; Prignano, F; Rongioletti, F; Hansel, K; Bianchi, L; Pescitelli, L; Lazzeri, L; Ricceri, F; Mugheddu, C; Bavetta, M; Zangrilli, A; Bianchi, L; Bini, V; Stingeni, L Articolo su rivista
3-ott-2019 Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation Lernia, Vd; Bianchi, L; Guerriero, C; Stingeni, L; Gisondi, P; Filoni, A; Guarneri, C; Belloni Fortina, A; Lasagni, C; Simonetti, O; Neri, I; Zangrilli, A; Moretta, G; Hansel, K; Casanova, Dm; Girolomoni, G; Cannavò, Sp; Bonamonte, D Articolo su rivista
Mostrati risultati da 1 a 20 di 30
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile